Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Sitagliptin & Type 2 Diabetes (T2D), sitagliptin is FDA approved in October 2006 (NDA 021995) as the first DPP-4 inhibitor; monotherapy or combo (e.g., metformin + sitagliptin). Recent: Zituvio TM (i.e., sitagliptin oral solution) in 2023/2025
sitagliptin-marketed-januvia-and-janumet-information
Sitagliptin is [EMA autorized](brain://QMGe2vnxWkWiArAahJp9aA/E…